GlassScriptPhysician profile
Caitlyn Colucci
NPI 1457708679
$649.03
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $49.97 · 2023: $435 · 2024: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $599.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $167.40 | 2023-2024 | Orgovyx, Gemtesa |
| Astrazeneca Pharmaceuticals LP | $117.94 | 2022-2023 | |
| Convatec INC. | $50.53 | 2023 | |
| Telix Pharmaceuticals | $49.82 | 2023-2024 | Illuccix |
| Baxter Healthcare | $48.35 | 2023 | Tisseel, Perclot |
| Teleflex LLC | $40.21 | 2024 | |
| Myovant Sciences INC. | $29.14 | 2022 | |
| Corcept Therapeutics | $28.45 | 2024 | Korlym |
| 180 Medical, INC. | $27.28 | 2024 | Gentlecath |
| Astellas Pharma Global Development | $25.74 | 2023 | Padcev |
| Coloplast Corp | $23.61 | 2023 | Speedicath |
| Urogen Pharma, INC. | $21.68 | 2024 | |
| Boston Scientific Corporation | $18.88 | 2023 | Spaceoar Vue System - 10ml |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlyn Colucci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.